152
Participants
Start Date
April 30, 2014
Primary Completion Date
May 31, 2015
Study Completion Date
October 31, 2016
75mg selumetinib
selumetinib tablets p.o. twice daily taken in combination with dacarbazine 1000mg/m2 iv on day 1 of every 21-day cycle.
placebo
placebo tablets p.o. twice daily taken in combination with dacarbazine 1000mg/m2 iv on day 1 of every 21-day cycle.
Dacarbazine
dacarbazine 1000mg/m2 iv on day 1 of every 21-day cycle taken in combination with either selumetinib or placebo tablets p.o. twice daily.
Research Site, Los Angeles
Research Site, Aurora
Research Site, Atlanta
Research Site, Lutherville
Research Site, St Louis
Research Site, New York
Research Site, Philadelphia
Research Site, Edegem
Research Site, Ghent
Research Site, Kortrijk
Research Site, Leuven
Research Site, Toronto
Research Site, Montreal
Research Site, Olomouc
Research Site, Prague
Research Site, Hus
Research Site, Nice
Research Site, Paris
Research Site, Heidelberg
Research Site, München
Research Site, Jerusalem
Research Site, Ramat Gan
Research Site, Leiden
Research Site, Barcelona
Research Site, L'Hospitalet de Llobregat
Research Site, Seville
Research Site, Valencia
Research Site, Glasgow
Research Site, Northwood
Research Site, Nottingham
Research Site, Swansea
Lead Sponsor
AstraZeneca
INDUSTRY